AstraZeneca has revealed that its top executive ... have involved cancer treatments Enhertu (trastuzumab deruxtecan), Imfinzi (durvalumab), or Imjudo (tremelimumab). Imfinzi was first approved ...

A spokesperson for AstraZeneca told pharmaphorum that the ... where AZ faces tough competition and its checkpoint inhibitors Imfinzi (durvalumab) and tremelimumab have failed to score the big ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 19,926.25 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

The Company History page lists out the major events in chronological order for AstraZeneca Pharma India Ltd. Company History - AstraZeneca Pharma India Ltd.